Hematological Malignancy: Clinical Trials

4 trials for Hematological Malignancy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 terminated. 4 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 14Terminated 4
Phase 21Terminated 1

Follow Hematological Malignancy: new trials by email Literature Review of Hematological Malignancy trials Research Report on Hematological Malignancy

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
SG2501 Safety Study in Subjects with Relapsed or Refractory Hematological Malignancies and Lymphoma.
SG2501 - Hematological Malignancy, Lymphoma
Phase 1TerminatedHangzhou Sumgen Biotech Co., Ltd.22023-03-032025-03-18
Safety and Preliminary Efficacy of ATG-017 Monotherapy or Combination Therapy With Nivolumab in Advanced Solid Tumors and Hematological Malignancies
ATG-017, ATG-017+Nivolumab - Solid Tumor, Hematological Malignancy
Phase 1TerminatedAntengene Therapeutics Limited362020-08-152024-07-23
Body Scan Activity on Bone Marrow Transplant Patients and Their Caregivers
Body Scan, Rotterdam Symptom Checklist, Practice Logs - Hematological Malignancy
Phase 1TerminatedWashington University School of Medicine372018-04-172018-10-31
Safety, PD & Efficacy of MT-3724 for the Treatment of Patients With Relapsed or Refractory DLBCL
MT-3724 Phase 1, MT-3724 Phase 2 - Non-Hodgkin's B-cell Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell
Phase 1 / Phase 2TerminatedMolecular Templates, Inc.382015-02-012022-08-18

Narrower conditions

Hematologic Neoplasms (4)  ·  Lymphoma (2)  ·  Leukemia (1)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (1)  ·  Lymphoma, B-Cell (1)  ·  Lymphoma, Large B-Cell, Diffuse (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Neoplasms (1)  ·  Recurrence (1)

Broader conditions

Hematologic Diseases (4)  ·  Hemic and Lymphatic Diseases (4)  ·  Neoplasms by Site (4)  ·  Neoplasms (3)  ·  Immune System Diseases (2)  ·  Immunoproliferative Disorders (2)  ·  Lymphatic Diseases (2)  ·  Lymphoproliferative Disorders (2)  ·  Neoplasms by Histologic Type (2)  ·  Chronic Disease (1)  ·  Disease Attributes (1)  ·  Leukemia, B-Cell (1)  ·  Leukemia, Lymphoid (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Antibodies, Bispecific (1)  ·  Whole Body Imaging (1)

Sponsors

Antengene Therapeutics Limited (1)  ·  Hangzhou Sumgen Biotech Co., Ltd. (1)  ·  Molecular Templates, Inc. (1)  ·  Washington University School of Medicine (1)

Countries

United States (3)  ·  Australia (1)  ·  Belarus (1)  ·  Canada (1)  ·  Georgia (1)  ·  Israel (1)  ·  Moldova (1)  ·  Poland (1)  ·  Serbia (1)  ·  Spain (1)  ·  Ukraine (1)

Top investigators

Anupa Kudva, MD (1)  ·  Maggie Compernolle, BSN, RN (1)  ·  Sai Lou, MD (1)  ·  Yiqiang Zhao, MD (1)